Elocon and Fenofibrate drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Elocon (mometasone furoate) and Fenofibrate (fenofibrate). Common drug interactions include confusional state among females and renal failure among males.

The phase IV clinical study analyzes what interactions people have when they take Elocon and Fenofibrate. It is created by eHealthMe based on reports of 14 people who take the same drugs from the FDA, and is updated regularly.

What is Elocon?

Elocon has active ingredients of mometasone furoate. It is often used in eczema. eHealthMe is studying from 2,019 Elocon users. Check the latest studies of Elocon.

What is Fenofibrate?

Fenofibrate has active ingredients of fenofibrate. It is often used in high blood cholesterol. eHealthMe is studying from 40,457 Fenofibrate users. Check the latest studies of Fenofibrate.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.



On Aug, 20, 2026

14 people who take Elocon and Fenofibrate together, and have interactions are studied.

Elocon and Fenofibrate drug interactions.

What are the common drug interactions of Elocon and Fenofibrate, by gender? *:

female:

  1. Confusional state
  2. Deafness
  3. Dementia (madness)
  4. Depressed mood
  5. Diarrhoea
  6. Dysarthria (speech disorder)
  7. Ear discomfort
  8. Gastrointestinal haemorrhage (bleeding gastrointestinal tract)
  9. Glomerular filtration rate decreased
  10. Hand deformity

male:

  1. Renal failure (kidney dysfunction)
  2. Death
  3. Pneumonia

What are the common drug interactions of Elocon and Fenofibrate, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

  1. Renal failure (kidney dysfunction)

50-59:

n/a

60+:

  1. Headache (pain in head)
  2. Herpes zoster
  3. Depressed mood
  4. Diarrhoea
  5. Dysarthria (speech disorder)
  6. Ear discomfort
  7. Gastrointestinal haemorrhage (bleeding gastrointestinal tract)
  8. Glomerular filtration rate decreased
  9. Hand deformity
  10. Influenza

What are the existing conditions these people have? *

  1. Pain: 6 people, 42.86%
  2. Chest Pain: 4 people, 28.57%
  3. Psoriasis (immune-mediated disease that affects the skin): 3 people, 21.43%
  4. Wheezing (a high-pitched whistling sound made while you breath): 2 people, 14.29%
  5. Nausea (feeling of having an urge to vomit): 2 people, 14.29%
  6. Atrial Fibrillation/flutter (atrial fibrillation and flutter are abnormal heart rhythms in which the atria, or upper chambers of the heart, are out of sync with the ventricles): 2 people, 14.29%
  7. Diarrhea: 2 people, 14.29%
  8. Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 2 people, 14.29%
  9. Muscle Aches (muscle pain): 2 people, 14.29%
  10. Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 2 people, 14.29%

* Approximation only. Some reports may have incomplete information.

Do you take Elocon and Fenofibrate?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Elocon and Fenofibrate:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Elocon:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Fenofibrate:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Elocon and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Fenofibrate and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on mometasone furoate and fenofibrate (the active ingredients of Elocon and Fenofibrate, respectively), and Elocon and Fenofibrate (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: